Category: New products
-
Health App Shown to Improve Asthma, Depression Outcomes
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.
-
Long-Acting Drug Start-Up Raises $4M in Seed Funds
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds.
-
Trial Advances of Dual-Action Cancer Immunotherapy
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study.
-
Digital Chemistry Start-Up Gains $43M in Early Funds
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
-
A.I. Analytics Detect Heart Failure in Single Ultrasound View
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart.
-
Streamlined Gene Therapy Delivery Process Demonstrated
A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive.
-
NIH Funds Depression Game Therapy Clinical Trial
A treatment for depression designed as a game for patients will be assessed in a clinical trial conducted by a university psychology lab and funded by National Institutes of Health.
-
Trial Cleared for Lab-Grown Replacement Knee Cartilage
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage.